pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
fostroxacitabine bralpamide hydrochloride
Hepatocellular Carcinoma
Medivir AB
0 catalysts
pre_registration
fovinaciclib
fovinaciclib [INN]
Breast Cancer
Shanghai Fosun Pharmaceutical (Group) Co Ltd
0 catalysts
Phase 2
fulzerasib
fulzerasib [INN]
Metastatic Colorectal Cancer
GenFleet Therapeutics (Shanghai) Inc
0 catalysts
Phase 3
← prev
page 47 of 62
next →
131
Pain89
Neurology1
furmonertinib mesylate
Non-Small Cell Lung Cancer
$AVBPArriVent BioPharma, Inc.
0 catalysts
Phase 3
galinpepimut-S
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Wilms tumor protein
$SLSSELLAS Life Sciences Group, Inc.
0 catalysts
Phase 2
garetatug rezetecan
garetatug rezetecan [INN]
Gastric Cancer
Jiangsu Hengrui Pharmaceuticals Co Ltd
0 catalysts
pre_registration
gedatolisib
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
PI3-kinase class ISerine/threonine-protein kinase mTOR
$CELCCelcuity Inc.
0 catalysts
Phase 2
gedeptin
Nasopharyngeal Cancer
$GOVXGeoVax Labs, Inc.
0 catalysts
Marketed
gefitinib
Gefitinib (gefitinib)
Non-Small Cell Lung Cancer
Actavis Laboratories NY Inc (Inactive)
0 catalysts
Phase 1
gemcitabine
Avgemsi (gemcitabine)
Pancreatic Cancer
Continuity Biosciences LLC
0 catalysts
Phase 2
gemogenovatucel-T
Vigil (gemogenovatucel-T)
Endometrial Cancer
Gradalis Inc
0 catalysts
Marketed
gemtuzumab ozogamicin
Mylotarg (gemtuzumab ozogamicin)
Refractory Acute Myeloid Leukemia
$PFEPFIZER INC
0 catalysts
Preclinical
gentulizumab
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Changchun High-Tech Industry Group Co Ltd
0 catalysts
Marketed
gilteritinib fumarate
Xospata (gilteritinib fumarate)
Refractory Acute Myeloid Leukemia
Astellas Pharma US Inc
0 catalysts
Phase 1
gintemetostat tartrate
Refractory Multiple Myeloma
K36 Therapeutics Inc
0 catalysts
pre_registration
giredestrant
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Estrogen receptor
Genentech Inc
0 catalysts
Marketed
givinostat hydrochloride
Duvyzat (givinostat hydrochloride)
Polycythemia Vera
Histone deacetylase
Italfarmaco SpA
0 catalysts
Marketed
glasdegib
Daurismo (glasdegib)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$PFEPFIZER INC
0 catalysts
Phase 2
glecirasib
glecirasib [INN]
Non-Small Cell Lung Cancer
Jacobio Pharmaceuticals Group Co Ltd
0 catalysts
Phase 3
glufosfamide
glufosfamide [INN]
Metastatic Adenocarcinoma of The Pancreas
Eleison Pharmaceuticals Inc
0 catalysts
Phase 2
gocatamig
Small-Cell Lung Cancer
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
golidocitinib
Peripheral T-Cell Lymphomas (PTCL)
Tyrosine-protein kinase JAK1
Dizal Pharmaceutical Co Ltd
0 catalysts
Phase 3
gotistobart
Non-Small Cell Lung Cancer
OncoC4 Inc
0 catalysts
Phase 2
guadecitabine sodium
Fallopian Tube Cancer
Astex Pharmaceuticals Inc
0 catalysts
Preclinical
guanidine hydrochloride
Unspecified Cancer
Kong's Pharmaceutical Co
0 catalysts
Phase 2
gumarontinib
gumarontinib [INN]
Non-Small Cell Lung Cancer
Shanghai Haihe Biopharma Co Ltd
0 catalysts
Phase 2
huMNC2-CAR22
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Minerva Biotechnologies Corp
0 catalysts
Phase 2
huMNC2-CAR44
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Minerva Biotechnologies Corp
0 catalysts
Marketed
human papillomavirus (virus like particle, 9-valent) vaccine
Gardasil 9
Cervical Intraepithelial Neoplasia (CIN)
$MRKMerck & Co., Inc.
0 catalysts
Marketed
hydrogen peroxide
hydrogen peroxide [USP]
Cervical Cancer
Kortuc Japan LLC
0 catalysts